

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sequestering of actin monomers (GO:0042989) | 4.13079907 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46914448 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.41356170 |
| 4 | negative regulation of cell killing (GO:0031342) | 3.35917481 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.35917481 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 3.32570306 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.32570306 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.22612439 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10017030 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 3.08449219 |
| 11 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.05086788 |
| 12 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.05086788 |
| 13 | electron transport chain (GO:0022900) | 2.97829432 |
| 14 | respiratory electron transport chain (GO:0022904) | 2.97092441 |
| 15 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.91056872 |
| 16 | phagosome maturation (GO:0090382) | 2.89776550 |
| 17 | * viral protein processing (GO:0019082) | 2.89497892 |
| 18 | GDP-mannose metabolic process (GO:0019673) | 2.81789312 |
| 19 | response to interferon-beta (GO:0035456) | 2.79119923 |
| 20 | regulation of autophagic vacuole assembly (GO:2000785) | 2.78264412 |
| 21 | viral transcription (GO:0019083) | 2.77239243 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74475908 |
| 23 | autophagic vacuole fusion (GO:0000046) | 2.74397866 |
| 24 | protein complex biogenesis (GO:0070271) | 2.68686677 |
| 25 | regulation of vacuole organization (GO:0044088) | 2.60279225 |
| 26 | amino sugar catabolic process (GO:0046348) | 2.57750949 |
| 27 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.55977231 |
| 28 | cellular response to interferon-beta (GO:0035458) | 2.55632843 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 2.54775533 |
| 30 | hydrogen ion transmembrane transport (GO:1902600) | 2.52662935 |
| 31 | platelet dense granule organization (GO:0060155) | 2.51108054 |
| 32 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.49188468 |
| 33 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48677427 |
| 34 | iron-sulfur cluster assembly (GO:0016226) | 2.48283985 |
| 35 | metallo-sulfur cluster assembly (GO:0031163) | 2.48283985 |
| 36 | base-excision repair, AP site formation (GO:0006285) | 2.45807677 |
| 37 | regulation of mast cell degranulation (GO:0043304) | 2.40219337 |
| 38 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.39158586 |
| 39 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.36553490 |
| 40 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.36553490 |
| 41 | NADH dehydrogenase complex assembly (GO:0010257) | 2.36553490 |
| 42 | neutrophil activation (GO:0042119) | 2.33133598 |
| 43 | detection of bacterium (GO:0016045) | 2.32266400 |
| 44 | translational termination (GO:0006415) | 2.32255868 |
| 45 | regulation of respiratory burst (GO:0060263) | 2.32083273 |
| 46 | proton transport (GO:0015992) | 2.31055447 |
| 47 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.29507912 |
| 48 | positive regulation of mast cell activation (GO:0033005) | 2.29008214 |
| 49 | hydrogen transport (GO:0006818) | 2.28704110 |
| 50 | glutathione biosynthetic process (GO:0006750) | 2.28336011 |
| 51 | negative regulation of innate immune response (GO:0045824) | 2.27040128 |
| 52 | lipoxygenase pathway (GO:0019372) | 2.26000783 |
| 53 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.25369003 |
| 54 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.24733126 |
| 55 | amyloid precursor protein catabolic process (GO:0042987) | 2.23260831 |
| 56 | regulation of mast cell activation (GO:0033003) | 2.22808628 |
| 57 | negative regulation of B cell apoptotic process (GO:0002903) | 2.21685506 |
| 58 | translational elongation (GO:0006414) | 2.21429429 |
| 59 | actin filament polymerization (GO:0030041) | 2.20117280 |
| 60 | protein insertion into membrane (GO:0051205) | 2.19880743 |
| 61 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19369353 |
| 62 | ATP biosynthetic process (GO:0006754) | 2.18943133 |
| 63 | arginine catabolic process (GO:0006527) | 2.18740908 |
| 64 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.17695025 |
| 65 | amine catabolic process (GO:0009310) | 2.17162969 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 2.17162969 |
| 67 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.16851534 |
| 68 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.16635533 |
| 69 | positive regulation of antigen processing and presentation (GO:0002579) | 2.16461954 |
| 70 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.15323957 |
| 71 | * virion assembly (GO:0019068) | 2.14858811 |
| 72 | neurotransmitter catabolic process (GO:0042135) | 2.13651951 |
| 73 | granulocyte activation (GO:0036230) | 2.13390057 |
| 74 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.13093490 |
| 75 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.12098110 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.10788266 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 2.09654905 |
| 78 | positive thymic T cell selection (GO:0045059) | 2.09177489 |
| 79 | leukocyte aggregation (GO:0070486) | 2.08975415 |
| 80 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.08784418 |
| 81 | * viral life cycle (GO:0019058) | 2.08753113 |
| 82 | response to peptidoglycan (GO:0032494) | 2.08453397 |
| 83 | actin nucleation (GO:0045010) | 2.08304563 |
| 84 | protein localization to endoplasmic reticulum (GO:0070972) | 2.07750059 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.07151098 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 2.07151098 |
| 87 | detection of other organism (GO:0098543) | 2.06404169 |
| 88 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.06250070 |
| 89 | protein targeting to ER (GO:0045047) | 2.04260806 |
| 90 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.04243172 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.03779810 |
| 92 | deoxyribonucleotide catabolic process (GO:0009264) | 2.02792063 |
| 93 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.02617273 |
| 94 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.02098449 |
| 95 | establishment of mitochondrion localization (GO:0051654) | 2.01316477 |
| 96 | cotranslational protein targeting to membrane (GO:0006613) | 2.00658781 |
| 97 | reactive oxygen species biosynthetic process (GO:1903409) | 2.00228057 |
| 98 | synaptic vesicle exocytosis (GO:0016079) | 1.99684900 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 1.99574744 |
| 100 | transferrin transport (GO:0033572) | 1.98673340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.95741618 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.80560888 |
| 3 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.42532111 |
| 4 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.40235005 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.26150250 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.24602615 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20424445 |
| 8 | * BCL6_27268052_Chip-Seq_Bcells_Human | 2.18362558 |
| 9 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.13823745 |
| 10 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.11025268 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.05783204 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01245292 |
| 13 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.93683865 |
| 14 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.91636738 |
| 15 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.90138677 |
| 16 | * P68_20966046_ChIP-Seq_HELA_Human | 1.88482750 |
| 17 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.84344263 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80110438 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75221085 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73967875 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71311100 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70812498 |
| 23 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.70085270 |
| 24 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.68333337 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.59917194 |
| 26 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.59180254 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57904095 |
| 28 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57142977 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56555477 |
| 30 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.55203777 |
| 31 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55065648 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54531520 |
| 33 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.52329672 |
| 34 | SA1_27219007_Chip-Seq_Bcells_Human | 1.52192000 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51603423 |
| 36 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.50547488 |
| 37 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.49834004 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49420482 |
| 39 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.49120313 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47324918 |
| 41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.46818353 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46263265 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45501703 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45144609 |
| 45 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.42866508 |
| 46 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.42167988 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41934917 |
| 48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39513343 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37237098 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36470023 |
| 51 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.35334668 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34139724 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33750009 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33311142 |
| 55 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.32052033 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30572330 |
| 57 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.28651011 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.27179762 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26821169 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.25535036 |
| 61 | * P300_27268052_Chip-Seq_Bcells_Human | 1.25449986 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22407247 |
| 63 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.21366942 |
| 64 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21326588 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20831233 |
| 66 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20808474 |
| 67 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20498609 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19941111 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19315662 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17312409 |
| 71 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15583495 |
| 72 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15344377 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 1.14080729 |
| 74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12631202 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12573238 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12019089 |
| 77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.11462951 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.11128736 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10159222 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08818798 |
| 81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.06747202 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06482294 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06409938 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06216210 |
| 85 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04724490 |
| 86 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03953330 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03853598 |
| 88 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03277309 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02775288 |
| 90 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00231568 |
| 91 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99629566 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98725940 |
| 93 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.98420801 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.98002432 |
| 95 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.96011994 |
| 96 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95954577 |
| 97 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.95085453 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94948931 |
| 99 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.94832741 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93414195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 2.83760420 |
| 2 | MP0003436_decreased_susceptibility_to | 2.69420944 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.56091993 |
| 4 | MP0002653_abnormal_ependyma_morphology | 2.29836207 |
| 5 | MP0005671_abnormal_response_to | 2.19072847 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.12180996 |
| 7 | MP0003011_delayed_dark_adaptation | 2.05523569 |
| 8 | MP0005464_abnormal_platelet_physiology | 1.94915998 |
| 9 | MP0005025_abnormal_response_to | 1.92874776 |
| 10 | MP0003172_abnormal_lysosome_physiology | 1.89847411 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 1.89431710 |
| 12 | MP0009840_abnormal_foam_cell | 1.85416812 |
| 13 | MP0002822_catalepsy | 1.72819692 |
| 14 | MP0009785_altered_susceptibility_to | 1.72538017 |
| 15 | MP0005387_immune_system_phenotype | 1.69507202 |
| 16 | MP0001790_abnormal_immune_system | 1.69507202 |
| 17 | MP0002419_abnormal_innate_immunity | 1.65560748 |
| 18 | MP0001905_abnormal_dopamine_level | 1.63302762 |
| 19 | MP0005000_abnormal_immune_tolerance | 1.63236751 |
| 20 | MP0000685_abnormal_immune_system | 1.60488501 |
| 21 | MP0003303_peritoneal_inflammation | 1.57541882 |
| 22 | MP0002723_abnormal_immune_serum | 1.53532990 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.52814725 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.52698267 |
| 25 | MP0001800_abnormal_humoral_immune | 1.49805110 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 1.47988402 |
| 27 | MP0009379_abnormal_foot_pigmentation | 1.45008922 |
| 28 | MP0005083_abnormal_biliary_tract | 1.40928439 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.40367517 |
| 30 | MP0009764_decreased_sensitivity_to | 1.40217914 |
| 31 | MP0006082_CNS_inflammation | 1.38980405 |
| 32 | MP0003866_abnormal_defecation | 1.37072976 |
| 33 | MP0008260_abnormal_autophagy | 1.37002191 |
| 34 | MP0002420_abnormal_adaptive_immunity | 1.36905740 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.36658685 |
| 36 | MP0001819_abnormal_immune_cell | 1.35986237 |
| 37 | MP0004859_abnormal_synaptic_plasticity | 1.35183175 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.33286575 |
| 39 | MP0003879_abnormal_hair_cell | 1.32165207 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.31287517 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.30738694 |
| 42 | MP0000604_amyloidosis | 1.30573058 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.28914802 |
| 44 | MP0001970_abnormal_pain_threshold | 1.27226002 |
| 45 | MP0000343_altered_response_to | 1.26483409 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.25213966 |
| 47 | MP0004142_abnormal_muscle_tone | 1.24617247 |
| 48 | MP0003075_altered_response_to | 1.24337826 |
| 49 | MP0003787_abnormal_imprinting | 1.23371939 |
| 50 | MP0001663_abnormal_digestive_system | 1.22300880 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.22180456 |
| 52 | MP0004858_abnormal_nervous_system | 1.14044730 |
| 53 | MP0001873_stomach_inflammation | 1.13734936 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.13089925 |
| 55 | MP0002132_abnormal_respiratory_system | 1.13007644 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.12682611 |
| 57 | MP0003329_amyloid_beta_deposits | 1.11425077 |
| 58 | MP0002933_joint_inflammation | 1.10208937 |
| 59 | MP0009278_abnormal_bone_marrow | 1.07137941 |
| 60 | MP0002736_abnormal_nociception_after | 1.05495976 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.04658335 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03563248 |
| 63 | MP0008469_abnormal_protein_level | 1.01829538 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.01152481 |
| 65 | MP0005535_abnormal_body_temperature | 1.01051945 |
| 66 | MP0004510_myositis | 1.00826533 |
| 67 | MP0009745_abnormal_behavioral_response | 1.00403353 |
| 68 | MP0005365_abnormal_bile_salt | 0.99222407 |
| 69 | MP0008872_abnormal_physiological_respon | 0.98281135 |
| 70 | MP0002064_seizures | 0.95601661 |
| 71 | MP0003880_abnormal_central_pattern | 0.94206624 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 0.93645966 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.93052250 |
| 74 | MP0005166_decreased_susceptibility_to | 0.92366194 |
| 75 | MP0000716_abnormal_immune_system | 0.91809362 |
| 76 | MP0004381_abnormal_hair_follicle | 0.91396259 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.90808820 |
| 78 | MP0002405_respiratory_system_inflammati | 0.90776120 |
| 79 | MP0001764_abnormal_homeostasis | 0.90137972 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.89996079 |
| 81 | MP0003635_abnormal_synaptic_transmissio | 0.88942023 |
| 82 | MP0002272_abnormal_nervous_system | 0.88880555 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.88866131 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.88244804 |
| 85 | MP0003186_abnormal_redox_activity | 0.87808432 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.86823273 |
| 87 | MP0005423_abnormal_somatic_nervous | 0.86735645 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.85145627 |
| 89 | MP0008874_decreased_physiological_sensi | 0.81404515 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.80672169 |
| 91 | MP0002063_abnormal_learning/memory/cond | 0.79360279 |
| 92 | MP0005360_urolithiasis | 0.79281034 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.78021418 |
| 94 | MP0003279_aneurysm | 0.77974061 |
| 95 | MP0000372_irregular_coat_pigmentation | 0.77497687 |
| 96 | MP0002557_abnormal_social/conspecific_i | 0.77186921 |
| 97 | MP0005645_abnormal_hypothalamus_physiol | 0.77157856 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.77122312 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.77122312 |
| 100 | MP0005390_skeleton_phenotype | 0.75274346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.80538024 |
| 2 | Mitochondrial inheritance (HP:0001427) | 3.52597281 |
| 3 | Petechiae (HP:0000967) | 3.49208450 |
| 4 | Hepatocellular necrosis (HP:0001404) | 3.48761532 |
| 5 | Acute necrotizing encephalopathy (HP:0006965) | 3.40115627 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.27763236 |
| 7 | Obstructive lung disease (HP:0006536) | 3.26032726 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 3.26032726 |
| 9 | Hepatic necrosis (HP:0002605) | 3.20023674 |
| 10 | Polyphagia (HP:0002591) | 3.10033149 |
| 11 | Purpura (HP:0000979) | 3.03270406 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.02721000 |
| 13 | Stomatitis (HP:0010280) | 3.00789229 |
| 14 | Myokymia (HP:0002411) | 2.89474621 |
| 15 | Dysostosis multiplex (HP:0000943) | 2.83890586 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.80766120 |
| 17 | Acute encephalopathy (HP:0006846) | 2.77812226 |
| 18 | Progressive macrocephaly (HP:0004481) | 2.75949005 |
| 19 | Prolonged bleeding time (HP:0003010) | 2.71856626 |
| 20 | Myositis (HP:0100614) | 2.65744765 |
| 21 | Recurrent abscess formation (HP:0002722) | 2.62284874 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.61353125 |
| 23 | Increased CSF lactate (HP:0002490) | 2.58539519 |
| 24 | Cerebral palsy (HP:0100021) | 2.55980854 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47152021 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47152021 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47152021 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 2.45638716 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 2.43108400 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 2.32377893 |
| 31 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.30781069 |
| 32 | Nasal polyposis (HP:0100582) | 2.29433501 |
| 33 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.28275208 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 2.27241211 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 2.26955741 |
| 36 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.26179225 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.26163277 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.25773814 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24762451 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24762451 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24762451 |
| 42 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.21882318 |
| 43 | Hypertensive crisis (HP:0100735) | 2.20004572 |
| 44 | Papilledema (HP:0001085) | 2.18629720 |
| 45 | Emotional lability (HP:0000712) | 2.16590012 |
| 46 | Increased muscle lipid content (HP:0009058) | 2.15140576 |
| 47 | Increased IgM level (HP:0003496) | 2.14016757 |
| 48 | Loss of speech (HP:0002371) | 2.12514465 |
| 49 | Abnormal ciliary motility (HP:0012262) | 2.11918440 |
| 50 | J-shaped sella turcica (HP:0002680) | 2.10772372 |
| 51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08801044 |
| 52 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.05925491 |
| 53 | Growth hormone excess (HP:0000845) | 2.05431470 |
| 54 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.04769212 |
| 55 | Abnormal eating behavior (HP:0100738) | 2.04524148 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.04193289 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.02544186 |
| 58 | Flat capital femoral epiphysis (HP:0003370) | 2.01669140 |
| 59 | Amyloidosis (HP:0011034) | 1.99831827 |
| 60 | Optic disc pallor (HP:0000543) | 1.98993378 |
| 61 | Severe visual impairment (HP:0001141) | 1.96702609 |
| 62 | Epistaxis (HP:0000421) | 1.93226619 |
| 63 | Joint stiffness (HP:0001387) | 1.92568127 |
| 64 | Increased IgE level (HP:0003212) | 1.91555372 |
| 65 | Orchitis (HP:0100796) | 1.91396750 |
| 66 | Agammaglobulinemia (HP:0004432) | 1.90357692 |
| 67 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90264606 |
| 68 | Mucopolysacchariduria (HP:0008155) | 1.90264606 |
| 69 | Lactic acidosis (HP:0003128) | 1.90025865 |
| 70 | Increased serum ferritin (HP:0003281) | 1.89443104 |
| 71 | Hyperlipoproteinemia (HP:0010980) | 1.89275503 |
| 72 | Oligomenorrhea (HP:0000876) | 1.88523436 |
| 73 | Hepatosplenomegaly (HP:0001433) | 1.85382484 |
| 74 | Agitation (HP:0000713) | 1.84728831 |
| 75 | Pustule (HP:0200039) | 1.84379168 |
| 76 | Encephalitis (HP:0002383) | 1.83425354 |
| 77 | Chronic sinusitis (HP:0011109) | 1.83344919 |
| 78 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.83164790 |
| 79 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.83164790 |
| 80 | Respiratory failure (HP:0002878) | 1.82094945 |
| 81 | Muscle fiber atrophy (HP:0100295) | 1.79529906 |
| 82 | Hyperthyroidism (HP:0000836) | 1.79156448 |
| 83 | Exertional dyspnea (HP:0002875) | 1.78985982 |
| 84 | Abnormal pupillary function (HP:0007686) | 1.78869451 |
| 85 | Axonal loss (HP:0003447) | 1.77821781 |
| 86 | Meningitis (HP:0001287) | 1.76114954 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 1.75961845 |
| 88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.75125571 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 1.74694823 |
| 90 | Dicarboxylic aciduria (HP:0003215) | 1.74061940 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74061940 |
| 92 | Cerebral edema (HP:0002181) | 1.73578091 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 1.73258935 |
| 94 | Delayed CNS myelination (HP:0002188) | 1.71004585 |
| 95 | Exercise intolerance (HP:0003546) | 1.70197928 |
| 96 | Abnormal number of erythroid precursors (HP:0012131) | 1.69865248 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.69509183 |
| 98 | Retinal dysplasia (HP:0007973) | 1.69385645 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 1.68694377 |
| 100 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68598691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 2.75775886 |
| 2 | MAP3K11 | 2.51032891 |
| 3 | TNK2 | 2.38659772 |
| 4 | EPHB1 | 2.31943697 |
| 5 | MAP4K1 | 2.25336513 |
| 6 | TESK1 | 2.20745235 |
| 7 | MAPK15 | 2.11260853 |
| 8 | NME2 | 2.06992155 |
| 9 | MAP4K2 | 2.05674029 |
| 10 | ERN1 | 2.01359080 |
| 11 | VRK2 | 1.99068680 |
| 12 | BCKDK | 1.83990469 |
| 13 | GRK6 | 1.83421770 |
| 14 | RIPK4 | 1.74720792 |
| 15 | LIMK1 | 1.57694940 |
| 16 | SIK3 | 1.51788293 |
| 17 | TBK1 | 1.49368577 |
| 18 | FES | 1.44741230 |
| 19 | TYK2 | 1.39467189 |
| 20 | DYRK1B | 1.35584164 |
| 21 | SIK1 | 1.34540335 |
| 22 | PIM2 | 1.31750258 |
| 23 | MUSK | 1.31520385 |
| 24 | SIK2 | 1.29238573 |
| 25 | TAOK3 | 1.24550585 |
| 26 | DYRK2 | 1.22521616 |
| 27 | BTK | 1.17666798 |
| 28 | MAP2K6 | 1.16532086 |
| 29 | ZAP70 | 1.16449391 |
| 30 | IRAK4 | 1.15802073 |
| 31 | MAP2K2 | 1.15776881 |
| 32 | MAP3K12 | 1.14787110 |
| 33 | EPHB2 | 1.14492042 |
| 34 | IKBKB | 1.10709942 |
| 35 | ARAF | 1.09398552 |
| 36 | MAP2K3 | 1.07272299 |
| 37 | DAPK1 | 1.06967004 |
| 38 | MAPKAPK3 | 1.06630361 |
| 39 | DAPK2 | 1.04707911 |
| 40 | CSK | 1.04451879 |
| 41 | PRKD3 | 1.03306701 |
| 42 | PRKD2 | 1.01781898 |
| 43 | BLK | 0.98400805 |
| 44 | MARK2 | 0.95810226 |
| 45 | MARK1 | 0.94631239 |
| 46 | IKBKE | 0.94046583 |
| 47 | TXK | 0.94039575 |
| 48 | ILK | 0.92846116 |
| 49 | SYK | 0.91550454 |
| 50 | GRK5 | 0.89809708 |
| 51 | ADRBK2 | 0.88974252 |
| 52 | MAPK13 | 0.88869025 |
| 53 | TLK1 | 0.88448772 |
| 54 | CDK19 | 0.88190106 |
| 55 | TAOK1 | 0.87001961 |
| 56 | MAP3K6 | 0.84411328 |
| 57 | LRRK2 | 0.81777165 |
| 58 | PHKG1 | 0.81378084 |
| 59 | PHKG2 | 0.81378084 |
| 60 | ABL2 | 0.78687808 |
| 61 | HCK | 0.78595269 |
| 62 | MAP2K4 | 0.78538615 |
| 63 | TAOK2 | 0.78518577 |
| 64 | NME1 | 0.76860775 |
| 65 | CAMKK1 | 0.76633453 |
| 66 | LYN | 0.76147550 |
| 67 | MAP2K7 | 0.73755570 |
| 68 | STK16 | 0.72796868 |
| 69 | MAPK12 | 0.72411478 |
| 70 | KDR | 0.72253616 |
| 71 | MAP3K3 | 0.71431801 |
| 72 | HIPK2 | 0.70944068 |
| 73 | DAPK3 | 0.69883663 |
| 74 | RPS6KA2 | 0.69790917 |
| 75 | BRAF | 0.68613540 |
| 76 | ITK | 0.67034816 |
| 77 | EPHA3 | 0.66295649 |
| 78 | PTK2B | 0.63768437 |
| 79 | MARK3 | 0.62158216 |
| 80 | GRK1 | 0.62007066 |
| 81 | MATK | 0.61599649 |
| 82 | KIT | 0.60822614 |
| 83 | PKN1 | 0.60026141 |
| 84 | CSF1R | 0.59484251 |
| 85 | TRIB3 | 0.57996119 |
| 86 | BMX | 0.57494427 |
| 87 | TEC | 0.55986391 |
| 88 | NTRK2 | 0.55030262 |
| 89 | LMTK2 | 0.54106657 |
| 90 | LCK | 0.54055504 |
| 91 | PINK1 | 0.53245780 |
| 92 | PRPF4B | 0.52776772 |
| 93 | CSNK1G3 | 0.50967619 |
| 94 | EPHA2 | 0.50485552 |
| 95 | RPS6KC1 | 0.50331645 |
| 96 | RPS6KL1 | 0.50331645 |
| 97 | ADRBK1 | 0.49514560 |
| 98 | MAPK4 | 0.49152600 |
| 99 | PRKCQ | 0.48036419 |
| 100 | PRKCI | 0.47691587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.82747401 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.07242856 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.64027126 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.34211130 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.22087255 |
| 6 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13098927 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.08258233 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98654703 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92675918 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.91190399 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.89575292 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.72724940 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72590268 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72170516 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.71699357 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71444795 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64416031 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63947291 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57137618 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51352356 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.50197148 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50119385 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49936730 |
| 24 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.45040026 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42169890 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.40357686 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40224155 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34629057 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.33673000 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.23568492 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22945605 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18252848 |
| 33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.17218751 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14749911 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13255079 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08542347 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07729176 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03121654 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.02412648 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98578733 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95411236 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94642078 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93253879 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92753801 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.92368794 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 0.91528015 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91105822 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.85658846 |
| 49 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85172515 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83405594 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82920864 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82869553 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81336637 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80989947 |
| 55 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77204786 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76274460 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75538598 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70071646 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.69581787 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67844081 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.67630663 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67057937 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66226572 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65679906 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.65443804 |
| 66 | * Endocytosis_Homo sapiens_hsa04144 | 0.64364698 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63285655 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.60939158 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.60901811 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58790627 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.58189542 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57721090 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56183780 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55853468 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55745980 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55520839 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54215146 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53910110 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53711292 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52710717 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51826586 |
| 82 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48120401 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46674312 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.46476316 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44071724 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | 0.43045249 |
| 87 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42724394 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42669662 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42098435 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.39925419 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39265793 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38790149 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.38049704 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38039661 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37591409 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.37251146 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36390686 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.34586966 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34513838 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34503746 |

